Term Name:	alpha-D-GlcpNAc-(1->3)-[P-6-[CH2]5NH2]-alpha-D-GlcpNAc-(1->2)-D-GroA
Synonyms:	(2R)-2-{[2-acetamido-3-O-(2-acetamido-2-deoxy-alpha-D-glucopyranosyl)-6-O-{[(5-aminopentyl)oxy](hydroxy)phosphoryl}-2-deoxy-alpha-D-glucopyranosyl]oxy}-3-hydroxypropanoic acid, (2R)-2-{[N-acetyl-alpha-D-glucosaminyl-(1->3)-N-acetyl-6-O-(5-aminopentylphospho)-alpha-D-glucosaminyl]oxy}-3-hydroxypropionic acid, 2-N-acetyl-alpha-D-glucosaminopyranosyl-(1->3)-2-N-acetyl-6-(5-aminopentylphosphoryl)-alpha-D-glucosaminopyranosyl-(1->2)-(2R)-3-hydroxypropanoic acid, alpha-D-GlcpNAc-(1->3)-alpha-D-GlcpNAc6(P-[CH2]5NH2)-(1->2)-D-GroA
Definition:	A synthetic disaccharide phosphate consisting of an alpha-D-GlcNAc-(1->3)-alpha-D-GlcNAc disaccharide linked glycosidically to O-2 of D-glyceric acid and connected to a 5-aminopentyl linker via a phospho group at O-6 of the reducing-end residue. Synthesized for immobilization on microarray surfaces and conjugation to carrier proteins as a potential vaccine candidate to protect from Clostridium difficile infections.
Ontology:	ChEBI [CHEBI:134200]  ( EBI )